New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
TG Therapeutics, Inc.
TGTX
Shape
US Flag

NASDAQ

EPS improving

EPS improving

4B

Biotechnology

Next Earning date - 06 Nov 2024

4B

Biotechnology

Next Earning date - 06 Nov 2024

22.90USD
Shape-0.23 ( -0.99%)
Market Open
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

-77%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated October 24, 2024
1W -1.73 % 1M -1.90 % 3M 14.65 % 1Y 226.31 %

Key Metrics

Shape
  • Market Cap

    3.55B


  • Shares Outstanding

    154.82M


  • Share in Float

    137.98M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    22.9


  • Average Volume

    3.57M


  • Beta

    2.208


  • Range

    6.89-26.41


  • Industry

    Biotechnology


  • Website

    https://www.tgtherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

37.55x

P/E Ratio

10.33x

P/S Ratio

18.85x

P/B Ratio

0.6

Debt/Equity

27.6%

Net Margin

$0.7

EPS

How TGTX compares to sector?

P/E Ratio

Relative Strength

Shape

TGTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$495M

Shape574%

2025-Revenue

$0.81

Shape1602%

2025-EPS

$387M

Shape-4456%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

upgrade

Previous: Sell

2023-08-02

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.26
vs -0.65

Q4.22

arrow
arrow

N/A

-0.39
vs -0.70

Q1.23

arrow
arrow

N/A

-0.28
vs -0.51

Q2.23

arrow
arrow

N/A

-0.34
vs -0.30

Q3.23

arrow
arrow

+381%

0.73
vs -0.26

Q4.23

arrow
arrow

N/A

-0.09
vs -0.39

Q1.24

arrow
arrow

N/A

-0.07
vs -0.28

Q2.24

arrow
arrow

+112%

0.04
vs -0.34

Q3.24

arrow
arrow

-97%

0.02
vs 0.73

Q4.24

arrow
arrow

+194%

0.08
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-95%

94K  vs 2M

Q4.22

arrow
arrow

-97%

80K  vs 2.3M

Q1.23

arrow
arrow

+287%

7.8M  vs 2M

Q2.23

arrow
arrow

+2606%

16.1M  vs 594K

Q3.23

arrow
arrow

+176299%

165.8M  vs 94K

Q4.23

arrow
arrow

+54864%

44M  vs 80K

Q1.24

arrow
arrow

+713%

63.5M  vs 7.8M

Q2.24

arrow
arrow

+357%

73.5M  vs 16.1M

Q3.24

arrow
arrow

-51%

81.2M  vs 165.8M

Q4.24

arrow
arrow

+124%

98.4M  vs 44M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-36%

-0.36
vs 0.03

Q4.22

arrow
arrow

+4%

0.04
vs -0.36

Q1.23

arrow
arrow

+2%

0.02
vs 0.04

Q2.23

arrow
arrow

+3%

0.03
vs 0.02

Q3.23

arrow
arrow

-8%

-0.08
vs 0.03

Q4.23

arrow
arrow

-9%

-0.09
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.09

Q2.24

arrow
arrow

+4%

0.04
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

198

198
vs 191

4%

Q4.22

arrow
arrow

221

221
vs 198

12%

Q1.23

arrow
arrow

229

229
vs 221

4%

Q2.23

arrow
arrow

274

274
vs 229

20%

Q3.23

arrow
arrow

258

258
vs 274

-6%

Q4.23

arrow
arrow

259

259
vs 258

0%

Q1.24

arrow
arrow

262

262
vs 259

1%

Q2.24

arrow
arrow

273

273
vs 262

4%

Earnings Growth

Latest News

TGTX

schaeffersresearch.com

10 hours ago